Related Experiment Videos
Risk factors for motor response complications in L-dopa-treated parkinsonian patients
A Peppe1, J M Dambrosia, T N Chase
1Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892.
Advances in Neurology
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Wearing-off detection in clinical practice: the wearing off real practice key (WORK-PD) study in Parkinson's disease.
Parkinsonism & related disorders·2014
Differential classification of dementia.
Behavioural neurology·2014
Changes in cerebral glucose metabolism with normal aging.
European journal of neurology·2013
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Weight of evidence in safety pharmacology guidance: A case for explicit probabilistic reasoning in the revision of ICH S7A.
Journal of pharmacological and toxicological methods·2026
Unveiling the in vivo fate of albumin-bound paclitaxel nanoparticles by UPLC-MS/MS based on free, protein bound, and total drug.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
A review of policy actions implemented during a toxic drug public health emergency in British Columbia, Canada (2016-2024).
The International journal on drug policy·2026
Severe antipsychotic-associated gastrointestinal hypomotility: AMSP pharmacovigilance data from 333,175 psychiatric inpatients.
European archives of psychiatry and clinical neuroscience·2026